Evidence map›Paper›PMID 38331798›Full record

ArticleCardiovascular diabetology2024

Association between atherogenic index of plasma control level and incident cardiovascular disease in middle-aged and elderly Chinese individuals with abnormal glucose metabolism.

Qianqian Min, Zhigang Wu, Jiangnan Yao, Siyi Wang, Lanzhi Duan, Sijia Liu, Mei Zhang, Yanhong Luo, Dongmei Ye, Yuxu Huang and 3 more

Open access · goldAbstract read
In one paragraph

Article in Cardiovascular diabetology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 110 papers.

0numbers the graph read from it
0cells of the map it votes in
110citing papers in PubMed
41.5field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

110 citing papers in PubMed, 116 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Observational
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Observational
  12. Article
  13. Article
  14. Observational
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article

50 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 3 institutions in 1 country.

Qianqian Min *Department of Cardiology, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, China.
Zhigang Wu *Department of Cardiology, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, China.
Jiangnan YaoCollege of Nursing, Wenzhou Medical University, Wenzhou, China.
Siyi WangDepartment of medicine, Jinggangshan University, Ji'an, Jiangxi province, China.
Lanzhi DuanDepartment of medicine, Jinggangshan University, Ji'an, Jiangxi province, China.
Sijia LiuDepartment of medicine, Jinggangshan University, Ji'an, Jiangxi province, China.
Mei ZhangDepartment of medicine, Jinggangshan University, Ji'an, Jiangxi province, China.
Yanhong LuoDepartment of medicine, Jinggangshan University, Ji'an, Jiangxi province, China.
Dongmei YeDepartment of medicine, Jinggangshan University, Ji'an, Jiangxi province, China.
Yuxu HuangDepartment of medicine, Jinggangshan University, Ji'an, Jiangxi province, China.
Lan ChenDepartment of Neurology, Affiliated Hospital of Jinggangshan University, Jinggangshan University, Ji'an, Jiangxi province, China. cljgsu@163.com.
Ke XuDepartment of Endocrinology, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, China. zjwzxuke@126.com.
Jianghua ZhouDepartment of Cardiology, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, China. zjhcchp@163.com.
Jinggangshan University · CNWenzhou Medical University · CNFirst Affiliated Hospital of Wenzhou Medical University · CN

Funding

This work was supported by the Wenzhou Science and Technology Bureau Project No. Y20220318Zhejiang Provincial Health Commission Project No. 2024KY1272
6 · The paper itself

Abstract

backgroundThe atherogenic index of plasma (AIP) and cardiovascular disease (CVD) in participants with abnormal glucose metabolism have been linked in previous studies. However, it was unclear whether AIP control level affects the further CVD incidence among with diabetes and pre-diabetes. Therefore, our study aimed to investigate the association between AIP control level with risk of CVD in individuals with abnormal glucose metabolism.

methodsParticipants with abnormal glucose metabolism were included from the China Health and Retirement Longitudinal Study. CVD was defined as self-reporting heart disease and/or stroke. Using k-means clustering analysis, AIP control level, which was the log-transformed ratio of triglyceride to high-density lipoprotein cholesterol in molar concentration, was divided into five classes. The association between AIP control level and incident CVD among individuals with abnormal glucose metabolism was investigated multivariable logistic regression analysis and application of restricted cubic spline analysis.

results398 (14.97%) of 2,659 participants eventually progressed to CVD within 3 years. After adjusting for various confounding factors, comparing to class 1 with the best control of the AIP, the OR for class 2 with good control was 1.31 (95% CI, 0.90-1.90), the OR for class 3 with moderate control was 1.38 (95% CI, 0.99-1.93), the OR for class 4 with worse control was 1.46 (95% CI, 1.01-2.10), and the OR for class 5 with consistently high levels was 1.56 (95% CI, 1.03-2.37). In restricted cubic spline regression, the relationship between cumulative AIP index and CVD is linear. Further subgroup analysis demonstrated that the similar results were observed in the individuals with agricultural Hukou, history of smoking, diastolic blood pressure ≥ 80mmHg, and normal body mass index. In addition, there was no interaction between the AIP control level and the subgroup variables.

conclusionsIn middle-aged and elderly participants with abnormal glucose metabolism, constant higher AIP with worst control may have a higher incidence of CVD. Monitoring long-term AIP change will contribute to early identification of high risk of CVD among individuals with abnormal glucose metabolism.

Indexed as

Cardiovascular DiseasesAgedChinaGlucoseHumansLongitudinal StudiesMiddle AgedRisk FactorsTriglyceridesGlucoseTriglyceridesAbnormal glucose metabolismAIP indexCHARLSCVD

Identifiers

PMID38331798
PMCPMC10854096
OpenAlexW4391640461

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.